Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab

PHASE2CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

September 30, 2012

Study Completion Date

January 31, 2013

Conditions
Hairy Cell Leukemia (HCL)
Interventions
DRUG

2CdA +/- Rituximab

Cladribine 0.14 mg/kg daily subcutaneous bolus injection Rituximab 375 mg/m² infusion

Trial Locations (47)

14467

Klinikum Ernst von Bergmann gGmbH, Potsdam

14471

St. Josefs-Krankenhaus, Potsdam

21073

Community based hemato-oncology medical office, Hamburg

24105

Community based hemato-oncology medical office, Kiel

26789

Community based hemato-oncology medical office, Leer

29221

Community based hemato-oncology medical office, Celle

30623

Meditinische Hochschule (MHH), Hanover

31134

Community based hemato-oncology medical office, Hildesheim

34125

Community based hemato-oncology medical office, Kassel

35037

Community based hemato-oncology medical office, Marburg

38440

Community based hemato-oncology medical office, Wolfsburg

39104

Community based hemato-oncology medical office, Magdeburg

40721

Community based hemato-oncology medical office, Hilden

44137

St.-Johannes-Hospital, Dortmund

44625

Marienhospital Herne/ Klinikum der Ruhr-Universität Bochum, Herne

47574

Wilhelm-Anton-Hospital, Goch

49076

MVZ Klinikum Osnabrück, Osnabrück

51375

Städtische Kliniken, Leverkusen

55743

Klinikum Idar-Oberstein, Idar-Oberstein

56068

Community based hemato-oncology medical office, Koblenz

56564

Community based hemato-oncology medical office, Neuwied

57072

St. Marien-Krankenhaus, Siegen

58095

Kath. Krankenhaus Hagen gem. GmbH, Hagen

60596

Universitätsklinik Frankfurt, Frankfurt am Main

61194

Community based hemato-oncology medical office, Niddatal

63739

Community based hemato-oncology medical office, Aschaffenburg

66538

Community based hemato-oncology medical office, Neunkirchen

69115

Community based hemato-oncology medical office, Heidelberg

70176

Diakonie-Klinikum Stuttgart, Stuttgart

73557

Klinik Schwäbisch Gmünd / Staufer Klinik, Mutlangen

73728

Städtische Kliniken Esslingen, Esslingen am Neckar

75179

Community based hemato-oncology medical office, Pforzheim

78050

Community based hemato-oncology medical office, Villingen

79106

Universitätsklinik Freiburg, Freiburg im Breisgau

80335

Community based hemato-oncology medical office, München

81241

Community based hemato-oncology medical office, München

81377

Klinikum Großhadern, München

90449

Community based hemato-oncology medical office, Nuremberg

90766

Community based hemato-oncology medical office, Fürth

91522

Community based hemato-oncology medical office, Ansbach

94315

Community based hemato-oncology medical office, Straubing

96317

Community based hemato-oncology medical office, Kronach

97421

Community based hemato-oncology medical office, Schweinfurt

Unknown

"University Clinic , Med. Cinic IV Justus-Liebig-University"

06108

Community based hemato-oncology medical office, Halle

07743

Community based hemato-oncology medical office, Jena

04103

Community based hemato-oncology medical office, Leipzig

All Listed Sponsors
lead

Jurgen Barth

OTHER

NCT02157181 - Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab | Biotech Hunter | Biotech Hunter